Home Cart Sign in  
Chemical Structure| 208260-29-1 Chemical Structure| 208260-29-1

Structure of ZM 336372
CAS No.: 208260-29-1

Chemical Structure| 208260-29-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

ZM336372 is an inhibitor of c-Raf with IC50 of 70 nM.

Synonyms: Zinc00581684

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of ZM 336372

CAS No. :208260-29-1
Formula : C23H23N3O3
M.W : 389.45
SMILES Code : CC1=C(C=C(C=C1)NC(C2=CC(N(C)C)=CC=C2)=O)NC(C3=CC=C(C=C3)O)=O
Synonyms :
Zinc00581684
MDL No. :MFCD02683971
InChI Key :PYEFPDQFAZNXLI-UHFFFAOYSA-N
Pubchem ID :5730

Safety of ZM 336372

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P280-P305+P351+P338-P304+P340-P405-P501

Related Pathways of ZM 336372

MAPK

Isoform Comparison

Biological Activity

Target
  • C-Raf/Raf-1

    C-Raf, IC50:70 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
NK cells 0.15 mg/ml, 1.15 mg/ml 6-8 days ZM336372 treatment increased cytokine production and degranulation marker expression in NK cells, although the differences were not statistically significant PMC6038007
Human medullary thyroid cancer cells (TT) 100-200 μM 4, 6, and 8 days ZM336372 significantly inhibited the growth of TT cells in a concentration-dependent manner. PMC2180346
Human bronchopulmonary carcinoid cells (H727) 100 μM 2 days Treatment with ZM336372 resulted in an increase in both phosphorylated ERK1/2 and GSK-3β proteins in H727 cells, along with a reduction in the levels of neuroendocrine markers CgA and ASCL1. PMC2180346

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.57mL

0.51mL

0.26mL

12.84mL

2.57mL

1.28mL

25.68mL

5.14mL

2.57mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories